Clinical Trials and Similar Human Studies
Last updated: 2022 Jan 4
Total hit(s): 4360
S.No.
1
34941607
Implementation of an Emergency Department-Embedded Infusion Center for the Administration of Monoclonal Antibody Therapy in Patients With Early COVID-19 Infection
J Infus Nurs
2022 Jan-Feb 01
1
2
34937699
SARS-CoV-2 spreads through cell-to-cell transmission
Proc Natl Acad Sci U S A
2022 Jan 4
9.35
2
3
34863618
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington
Vaccine
2022 Jan 3
3.31
1
4
34875467
Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro
Bioorg Med Chem
2022 Jan 1
1
5
34630624
Epidemic model dynamics and fuzzy neural-network optimal control with impulsive traveling and migrating: Case study of COVID-19 vaccination
Biomed Signal Process Control
2022 Jan
3.83
1
6
34901799
Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
EClinicalMedicine
2022 Jan
6.68
1
7
34938959
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals
Hemasphere
2022 Jan
1
8
34926119
COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review
3 Biotech
2022 Jan
2.27
1
9
34243904
Clinical Management of COVID-19 Patients - An Update
Semin Nucl Med
2022 Jan
3
10
34901912
Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany
Lancet Reg Health Eur
2022 Jan
n/a
2
11
34950394
Cryptococcal Meningoencephalitis During Convalescence From Severe COVID-19 Pneumonia
Neurohospitalist
2022 Jan
2
12
34934447
Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial
Exp Ther Med
2022 Jan
1.49
1
13
34896578
An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 Neutralizing antibody levels in COVID-19 patients and vaccinees
Int J Infect Dis
2021 Dec 9
3.42
1
14
34917247
Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19
ACS Med Chem Lett
2021 Dec 9
3.75
1
15
34946540
Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment
Molecules
2021 Dec 9
3.01
1
16
34896122
Comparisons of the immunological landscape of COVID-19 patients based on sex and disease severity by multi-omics analysis
Chem Biol Interact
2021 Dec 9
3.45
1
17
34945060
Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 Pneumonia
J Clin Med
2021 Dec 9
6.78
1
18
34880010
Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden
BMJ Open
2021 Dec 8
2.49
1
19
34886784
From Bench Side to Bed-Travelling on a Road to Get a Safe and Effective Vaccine Against COVID-19, Day to Save the Life
Recent Pat Biotechnol
2021 Dec 8
1
20
34920226
Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination
Biosens Bioelectron
2021 Dec 8
9.52
1
21
34878955
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
Infect Dis (Lond)
2021 Dec 8
1.23
1
22
34878625
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2
Infect Dis Ther
2021 Dec 8
3.95
1
23
34878902
Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection
J Virol
2021 Dec 8
4.16
1
24
34909785
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
medRxiv
2021 Dec 8
Cant find
1
25
34909781
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report
medRxiv
2021 Dec 7
Cant find
1